title: Somatostatin analog withdrawal in patients with acromegaly: an elusive goal?
authors.affiliation: Experimental Endocrinology Unit, Hospital de Especialidades, Centro Médico Nacional, Siglo XXI, IMSS, Aristóteles 68, Polanco, 11560, Mexico City, Mexico, moises.mercado@endocrinologia.org.mx.
authors.forename: Moisés
authors.initials: M
authors.lastname: Mercado
mesh_terms: D000172:Acromegaly / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D015282:Octreotide / Q000627:therapeutic use*; D013004:Somatostatin / Q000031:analogs & derivatives*
chemical_list: D013004:Somatostatin; D015282:Octreotide
references.citation: Clin Endocrinol (Oxf). 2003 Mar;58(3):288-95
references.pmid: 12608933
references.citation: Eur J Endocrinol. 2012 Jan;166(1):21-6
references.pmid: 21993154
references.citation: Pituitary. 2011 Sep;14(3):284-94
references.pmid: 21597975
references.citation: Clin Endocrinol (Oxf). 2004 Aug;61(2):224-31
references.pmid: 15272918
references.citation: Pituitary. 2000 Nov;3(3):193-7
references.pmid: 11383486
references.citation: Pituitary. 2011 Jun;14(2):125-33
references.pmid: 21063787
references.citation: J Clin Endocrinol Metab. 2001 Nov;86(11):5194-200
references.pmid: 11701676
references.citation: Curr Opin Endocrinol Diabetes Obes. 2011 Aug;18(4):264-8
references.pmid: 21844709
references.citation: Clin Endocrinol (Oxf). 1999 Mar;50(3):295-9
references.pmid: 10435053
references.citation: Eur J Endocrinol. 2008 Jan;158(1):19-25
references.pmid: 18166813
references.citation: J Clin Endocrinol Metab. 2005 Nov;90(11):6156-61
references.pmid: 16091489
references.citation: Pituitary. 2014 Jan;17 Suppl 1:S4-10
references.pmid: 24166706
references.citation: Endocrine. 2014 Aug;46(3):577-84
references.pmid: 24272601
references.citation: Pituitary. 2011 Jun;14(2):184-93
references.pmid: 21161602
references.citation: J Clin Endocrinol Metab. 2008 Aug;93(8):2957-68
references.pmid: 18477663